Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.84 USD | +1.90% | +2.48% | +37.27% |
May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.27% | 3.78B | |
+30.34% | 48.16B | |
-0.12% | 41.73B | |
+43.12% | 41.03B | |
-5.31% | 28.77B | |
+10.88% | 25.59B | |
-22.11% | 18.96B | |
+8.86% | 12.92B | |
+28.21% | 12.03B | |
-2.79% | 11.77B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals' Initial Phase 2 Data of Paltusotine for Carcinoid Syndrome Shows Reductions in Bowel Movements